Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ADALIMUMAB-ADAZ (HYRIMOZ) and ADALIMUMAB-RYVK (Simlandi) — clinical data, side effects, and patient experiences.
HYRIMOZ · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Simlandi · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 9 Reddit discussions
ADALIMUMAB-ADAZ
0%
positive
2 threads
ADALIMUMAB-RYVK
29%
positive
7 threads
% of discussions mentioning each side effect
2 Reddit threads analysed for ADALIMUMAB-ADAZ
Overall Sentiment
Mixed
Comparison Threads
1
Avg Post Score
2 upvotes
Threads directly comparing ADALIMUMAB-ADAZ to other medications
Sex: Male. Location: CANADA. Age: 29. Ethnicity: White. Medication: Adalimumab-adaz. Medical History: Psoriasis, Family history of heart problems including heart related deaths before 40 of atleast 2 family members including my father. I’m a 29 male, 5’10” tall, 155lbs, I weight train i
When I was first diagnosed with Crohn's over 2 yrs ago I was put on Humira, and their rebate program saved me. My cost would have been nearly $12k a month but thankfully it went to $5 until I hit my OOP Max, and then the insurance company picked up the cost. Now I have been switched to the generic
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
7 Reddit threads analysed for ADALIMUMAB-RYVK
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
4 upvotes
Most discussed side effects in community
I’m a 49M Crohn’s veteran, pretty new to Reddit. I’ve been on Humira for the past 10 years with fantastic results. By far the longest remission period since I was diagnosed in 1986. Last summer I had a skin cancer spot on my ear, a basal cell. Had it removed via Moh’s surgery. Now I have another spo
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Lt
SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® PARSIPPANY, N.J. & REYKJAVÍK, Iceland--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced t
* In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI * SELARSDI is the second biosimilar to launch in the U.S. under t
February 23, 2024 8:15 PM SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership between Alvotech and Teva in the U.S. market SIMLANDI will qualify for intercha
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S. commercialization agreement with Teva Pharmaceuticals The high-concentration interchangeable biosimilar to Hum
* Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis * The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection i
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Both ADALIMUMAB-ADAZ and ADALIMUMAB-RYVK belong to the TNF Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.
Both medications are approved for inducing major clinical response, inhibiting the progression of structural damage, inhibiting the progression of structural damage, posterior. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
ADALIMUMAB-ADAZ carries 4 FDA warnings. ADALIMUMAB-RYVK carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.